Results 141 to 150 of about 2,347,326 (232)

Altered B-cell receptor signaling kinetics distinguish human follicular lymphoma B cells from tumor-infiltrating nonmalignant B cells.

Blood, 2006
J. Irish, D. Czerwinski, G. Nolan, R. Levy   +3 more
semanticscholar   +1 more source

STAT6: Multidimensional analysis from hematopoietic immune regulation to pathogenesis mechanisms and therapeutic targets in hematologic malignancies. [PDF]

Ann Hematol
Zhang S, Xiong S, Liu X, Cao J, Yue N, Wu C.   +5 more
europepmc   +1 more source

Targetable Vulnerabilities in MYC-Driven B Cell Lymphomas Resistant to BCR Extinction. [PDF]

Hematol Oncol
Brambillasca S, Chantal Parr N, Palmeri A, Andronache A, Arima H, Faga' G, Leuzzi B, Perucho L, Robusto M, Pasi M, Mainoldi F, Fancelli D, Varasi M, Varano G, Mercurio C, Casola S.   +15 more
europepmc   +1 more source

Primary Breast Lymphoma in Mexico: A 15-Year Retrospective Case Series From a Tertiary Center Suggesting a Distinctly Early Age at Presentation. [PDF]

Cureus
Teco-Cortes JA, Navarrete-Pérez JJ, Sánchez-Castro OE, de Los Santos-Farrera O.   +3 more
europepmc   +1 more source

Chemotherapy-refractory diffuse large B-cell lymphoma and indolent B-cell malignancies can be effectively treated with autologous T cells expressing an anti-CD19 chimeric antigen receptor.

Journal of Clinical Oncology, 2015
J. Kochenderfer, M. Dudley, Sadik H. Kassim, R. Somerville, R. O. Carpenter, M. Stetler-Stevenson, J. Yang, G. Phan, M. Hughes, R. Sherry, M. Raffeld, Steven R. Feldman, Lily Lu, Yong F Li, L. Ngo, A. Goy, T. Feldman, D. Spaner, Michael L. Wang, Clara C. Chen, S. Kranick, A. Nath, Debbie-Ann N. Nathan, K. Morton, M. A. Toomey, S. Rosenberg   +25 more
semanticscholar   +1 more source

Advances in Nanotechnology for Lymphoma Treatment: Targeted Delivery, Immunomodulation, and TME-Responsive Therapy Strategies. [PDF]

Int J Nanomedicine
Han B, Han Z, Zhang Y.
europepmc   +1 more source

Case Report: Clonal evolution of diffuse large B-cell lymphoma to plasmablastic lymphoma: diagnostic challenges in a case of gastric lesion with EBV-negative PBL. [PDF]

Front Oncol
Xu J, Liu Y, Feng X, Zhao D, Liu K, Cui S, Wang Y.   +6 more
europepmc   +1 more source

B-cell lymphoma initially presenting as isolated pleural effusion: a challenging diagnostic case report. [PDF]

Transl Cancer Res
Chen Y, Hao Y, Zhao W, Zhang N, Zhou Y.
europepmc   +1 more source

Genetic and Transcriptomic Profiles Identify Potential Therapeutic Targets of Concurrent Follicular and Diffuse Large B-Cell Lymphoma and Transformed Follicular Lymphoma. [PDF]

Hematol Oncol
Sun R, Li RC, Li HY, Wang N, Xu TY, Tian S, Fu D, Li C, Zhang FY, Feng Y, Cheng S, Xu PP, Wang L, Zheng Z, Zhao WL.   +14 more
europepmc   +1 more source

B cell lymphoma

, 2016
B cell lymphoma is the most common hematologic malignancy. Besides alterations in the malignant lymphoma cells, also the interaction with the microenvironment has gained much interest in recent years. The aim of this thesis is to characterize the malignant cells as well as the surrounding microenvironment by proteomics and by flow analysis.In the first
openaire   +1 more source